Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion and Naltrexone for Binge Drinking
NCT02842073Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone, bupropion in alcohol use disorder (AUD), sponsored by University of North Carolina at Chapel Hill. Started Nov 2016; status: completed.
02
Drugs
naltrexonebupropion
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02842073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02842073.